Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024GlobeNewsWire • 09/30/24
Medincell's Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI for Adult Patients Diagnosed with SchizophreniaBusiness Wire • 09/23/24
Medincell's Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris®Business Wire • 09/23/24
Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive DyskinesiaGlobeNewsWire • 09/23/24
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with SchizophreniaGlobeNewsWire • 09/21/24
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)GlobeNewsWire • 09/21/24
Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference (Transcript)Seeking Alpha • 09/19/24
Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources sayReuters • 09/10/24
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of StabilityBenzinga • 09/06/24
Medincell's Partner Teva Provides New Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI)Business Wire • 09/05/24
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/05/24
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewsWire • 08/26/24
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call TranscriptSeeking Alpha • 07/31/24
Medincell's partner Teva provides update on pivotal clinical Phase 3 of investigational Olanzapine Long-Acting Injectable (LAI) and UZEDY® commercial progressBusiness Wire • 07/31/24
Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 07/31/24
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?Zacks Investment Research • 07/31/24